Glucose metabolism alterations in patients with bipolar disorder

Gianluca Rosso, Annamaria Cattaneo, Roberta Zanardini, Massimo Gennarelli, Giuseppe Maina, Luisella Bocchio-Chiavetto

Research output: Contribution to journalArticlepeer-review


Patients with bipolar disorder (BD) are more frequently affected by metabolic syndrome (MetS) than the general population, but the neurobiological correlates underlying such association are still not clarified and few studies in BD have evaluated the role of regulators of lipid and glucose metabolism. The present study was aimed to investigate putative alterations in markers linked to metabolic dysfunctions as C-peptide, Ghrelin, GIP, GLP-1, Glucagon, Insulin, Leptin, PAI-1 (total), Resistin and Visfatin in a sample of BD patients compared to controls. Furthermore, associations between changes of metabolic markers and relevant clinical features, such as severity of symptomatology, number and type of past mood episodes, drug treatments and presence/absence of metabolic alterations (MetS, diabetes and cardiovascular disease) were analyzed. A total of 57 patients with BD and 49 healthy controls were recruited. The main results showed lower serum levels of Glucagon, GLP-1, Ghrelin, and higher levels of GIP in BD patients as compared to controls (p=0.018 for Ghrelin; p

Original languageEnglish
Pages (from-to)293-298
Number of pages6
JournalJournal of Affective Disorders
Publication statusPublished - Jun 29 2015


  • Bipolar disorder
  • Ghrelin
  • Glucagon
  • Incretins
  • Metabolic syndrome
  • Serum

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology


Dive into the research topics of 'Glucose metabolism alterations in patients with bipolar disorder'. Together they form a unique fingerprint.

Cite this